শুধুমাত্র তথ্যমূলক — চিকিৎসা পরামর্শ নয়। সর্বদা লাইসেন্সপ্রাপ্ত স্বাস্থ্যসেবা প্রদানকারীর পরামর্শ নিন।

MedBD
EN
Community data Updated 2 মাস আগে
🌐 View in English

ইঙ্গিত

Osteoarthritis Rheumatoid Arthritis

Melcam is used to treat osteoarthritis, rheumatoid arthritis, and ankylosing spondylitis.

⚠️ কোনো ওষুধ গ্রহণের আগে সর্বদা নিবন্ধিত চিকিৎসকের পরামর্শ নিন।

ফার্মাকোলজি

Meloxicam belongs to the oxicam group of non-steroidal anti-inflammatory drugs (NSAIDs) and provides anti-inflammatory, pain-relieving and fever-reducing effects. When taken by mouth, it is well absorbed, with an average bioavailability of 89%. At the standard doses of 7.5 mg and 15 mg, blood levels rise in proportion to the dose taken, averaging 0.4 to 1.0 mg/litre with 7.5 mg and 0.8 to 2.0 mg/litre with 15 mg. Once in the bloodstream, meloxicam binds very strongly (about 99%) to plasma proteins, mainly albumin. The body breaks it down extensively in the liver, mainly by oxidising the methyl group attached to its thiazolyl ring, and only about 3% of a dose leaves the body unchanged. The remainder is cleared roughly equally through the urine and the stool, and on average it takes about 20 hours for half of the drug to be eliminated from the body.

Pregnancy & Breastfeeding

Meloxicam is best avoided during pregnancy. It is also not known whether it passes into breast milk, so nursing mothers should not take it.

⚠️ Talk to your doctor before taking any medicine during pregnancy or while breastfeeding.

ডোজ নির্দেশিকা

⚠️ শুধুমাত্র সরকারি উৎস থেকে নির্দেশিকা পরিসীমা। ব্যক্তিগতকৃত ডোজের জন্য আপনার ডাক্তারের পরামর্শ নিন।

Adults: For Adults: Osteoarthritis: 7.5 mg per day, which can be raised to 15 mg per day if it doesn't provide enough improvement. Rheumatoid arthritis: 15 mg per day, though elderly patients should keep to 7.5 mg per day for long-term treatment. Ankylosing spondylitis: 15 mg per day, or 7.5 mg per day in elderly patients. The dose should not go above 15 mg/day, and the full daily amount is taken as a single dose. Adults at higher risk of adverse reactions should begin treatment at 7.5 mg/day, and dialysis patients with severe renal failure should not exceed 7.5 mg/day. For Children: Meloxicam's pharmacokinetics in paediatric patients under 18 years of age have not been studied.

পার্শ্বপ্রতিক্রিয়া ও পারস্পরিক ক্রিয়া

পার্শ্বপ্রতিক্রিয়া

No side-effect data recorded yet.

প্রধান পারস্পরিক ক্রিয়া

Checker →